VeriMom¿Debo evitar retinoyl oligopeptide-112 durante el embarazo? | VeriMom
No EU ban or harmonised CLP classification was found for Retinoyl Oligopeptide‑112, but the ingredient contains a retinoyl (vitamin‑A) moiety. EU/SCCS guidance treats some retinoids (e.g., retinoic acid) as prohibited and limits other vitamin A derivatives because of developmental/embryotoxic concern; by your scoring rules a structural/class-based concern (retinoid moiety) justifies h=1 and a theoretical mechanism justifies m=1. No specific reproductive/teratology animal or human data for this exact INCI were located. (Sources: cosmile ingredient entry; SCCS opinion on vitamin A; EU Annex II/III context.).
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- ¿Es retinoyl oligopeptide-112 seguro durante el embarazo?
- No EU ban or harmonised CLP classification was found for Retinoyl Oligopeptide‑112, but the ingredient contains a retinoyl (vitamin‑A) moiety. EU/SCCS guidance treats some retinoids (e.g., retinoic acid) as prohibited and limits other vitamin A derivatives because of developmental/embryotoxic concern; by your scoring rules a structural/class-based concern (retinoid moiety) justifies h=1 and a theoretical mechanism justifies m=1. No specific reproductive/teratology animal or human data for this exact INCI were located. (Sources: cosmile ingredient entry; SCCS opinion on vitamin A; EU Annex II/III context.).
- ¿Es retinoyl oligopeptide-112 seguro durante la lactancia?
- No specific data on milk excretion for this ingredient were located. Topical retinoids are generally advised against in pregnancy and often avoided during breastfeeding as a precaution; because the compound contains a retinoyl group there is a class‑based/theoretical concern (h=1, m=1). Measured systemic absorption for retinoid‑peptide conjugates was not found, so exposure scored as low but measurable (e=1).
- ¿Es retinoyl oligopeptide-112 seguro para la piel del bebé?
- Infant skin has higher permeability; per your rules increase exposure by +1 when adult exposure is measurable. No infant‑specific safety data were found for Retinoyl Oligopeptide‑112; therefore h and m remain the same as adults (structural/class concern), and e is increased to 2 for 0–3‑year‑old skin. Keep infants’ direct contact with treated skin minimal (no application to chest/areas the baby may contact) in the absence of data.
- ¿Cómo puntúa VeriMom a retinoyl oligopeptide-112?
- VeriMom puntúa retinoyl oligopeptide-112 en 13/100 (riesgo alto) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a retinoyl oligopeptide-112 en el embarazo?
- Consulta nuestra lista de alternativas seguras a retinoyl oligopeptide-112 según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.